| COVID-19 cytokine storm: The anger of inflammation M Mahmudpour, J Roozbeh, M Keshavarz, S Farrokhi, I Nabipour Cytokine, 155151, 2020 | 507 | 2020 |
| Novel Coronavirus Disease 2019 (COVID-19): An Emerging Infectious Disease in the 21st Century A Tavakoli, K Vahdat, M Keshavarz ISMJ 22 (6), 432-450, 2020 | 265 | 2020 |
| Influenza vaccine: Where are we and where do we go? M Keshavarz, H Mirzaei, M Salemi, F Momeni, MJ Mousavi, ... Reviews in medical virology, e2014, 2018 | 84 | 2018 |
| Potential natural products against respiratory viruses: A perspective to develop anti-COVID-19 medicines M Omrani, M Keshavarz, S Nejad Ebrahimi, M Mehrabi, LJ McGaw, ... Front. Phys. 11: 586993. doi: 10.3389/fphar, 2021 | 70 | 2021 |
| Inactivation methods for whole influenza vaccine production A Sabbaghi, SM Miri, M Keshavarz, M Zargar, A Ghaemi Reviews in medical virology, e2074, 2019 | 70 | 2019 |
| Metabolic host response and therapeutic approaches to influenza infection M Keshavarz, F Solaymani-Mohammadi, H Namdari, Y Arjeini, ... Cellular & Molecular Biology Letters 25 (1), 1-19, 2020 | 63 | 2020 |
| Oncolytic Newcastle disease virus reduce growth of cervical cancer cell by inducing apoptosis M Keshavarz, ASM Nejad, M Esghaei, F Bokharaei-Salim, ... Saudi Journal of Biological Sciences, 2019 | 56 | 2019 |
| miRNA-based strategy for modulation of influenza A virus infection M Keshavarz, H Dianat-Moghadam, VH Sofiani, M Karimzadeh, M Zargar, ... Epigenomics, 2018 | 53 | 2018 |
| TRAIL in oncology: From recombinant TRAIL to nano-and self-targeted TRAIL-based therapies H Dianat-Moghadam, M Heidarifard, A Mahari, M Shahgolzari, ... Pharmacological Research, 104716, 2020 | 52 | 2020 |
| Association between human papillomavirus infection and prostate cancer: A global systematic review and meta-analysis. M Moghoofei, M Keshavarz, S Ghorbani, F Babaei, JS Nahand, ... Asia-Pacific journal of clinical oncology, 2019 | 52 | 2019 |
| Role of γδ T cells in controlling viral infections with a focus on influenza virus: implications for designing novel therapeutic approaches A Sabbaghi, SM Miri, M Keshavarz, M Mahooti, A Zebardast, A Ghaemi Virology Journal 17 (1), 1-18, 2020 | 47 | 2020 |
| Association of polymorphisms in inflammatory cytokines encoding genes with severe cases of influenza A/H1N1 and B in an Iranian population M Keshavarz, H Namdari, M Farahmand, P Mehrbod, T Mokhtari-Azad, ... Virology Journal 16 (1), 79, 2019 | 47 | 2019 |
| Oncolytic Newcastle disease virus delivered by Mesenchymal stem cells-engineered system enhances the therapeutic effects altering tumor microenvironment M Keshavarz, MS Ebrahimzadeh, SM Miri, H Dianat-Moghadam, ... Virology Journal 17 (1), 1-13, 2020 | 38 | 2020 |
| Key elements of preparedness for pandemic coronavirus disease 2019 (COVID-19) in nuclear medicine units M Assadi, A Gholamrezanezhad, N Jokar, M Keshavarz, M Picchio, ... European Journal of Nuclear Medicine and Molecular Imaging, 1, 2020 | 35 | 2020 |
| Gold Nanoparticles: Multifaceted Roles in the Management of Autoimmune Disorders K Koushki, S Keshavarz Shahbaz, M Keshavarz, EE Bezsonov, ... Biomolecules 11 (9), 1289, 2021 | 33 | 2021 |
| Role of Myeloid-derived suppressor cells in viral respiratory infections; Hints for Discovering Therapeutic Targets for COVID-19 K Koushki, M Salemi, SM Miri, Y Arjeini, M Keshavarz, A Ghaemi Biomedicine & Pharmacotherapy, 112346, 2021 | 30 | 2021 |
| Correction to: Oncolytic paramyxoviruses-induced autophagy; a prudent weapon for cancer therapy M Keshavarz, F Solaymani-Mohammadi, SM Miri, A Ghaemi Journal of biomedical science 26 (1), 54, 2019 | 28* | 2019 |
| Oncolytic paramyxoviruses-induced autophagy; a prudent weapon for cancer therapy M Keshavarz, F Solaymani-Mohammadi, SM Miri, A Ghaemi Journal of Biomedical Science 26 (1), 48, 2019 | 28 | 2019 |
| Epidemiology of rotavirus in the Iranian children: A systematic review and meta-analysis SHR Monavari, S Hadifar, S Mostafaei, A Miri, M Keshavarz, F Babaei, ... Journal of Global Infectious Diseases 9 (2), 66, 2017 | 28 | 2017 |
| Immunopathology and Immunopathogenesis of COVID-19, what we know and what we should learn M Shahgolzari, A Yavari, Y Arjeini, SM Miri, A Darabi, ASM Nejad, ... Gene Reports, 101417, 2021 | 23 | 2021 |
